Claims
- 1. A derivative of taurine represented by the formula:
- (CH.sub.3 --CO--NH--CH.sub.2 --CH.sub.2 --SO.sub.3).sup.- Li.sup.+.
- 2. A compound according to claim 1 used as drugs, in particular as agents having a reinforced neuromuscular activity.
- 3. Pharmaceutical compositions containing as active ingredient a compound according to claim 1 associated with a suitable excipient for administration by the oral, parenteral or local route.
- 4. Orally administered forms of the compositions according to claim 3, containing the active ingredient at the unitary dose of 0.30 g to 1 g for capsules, sugar-coated pills, tablets, gelatin-coated capsules, and from 3 to 5 g/10 ml for the solutions.
- 5. Parenterally administered forms of the compositions according to claim 4, containing the active ingredient at a dose of 0.5 to 2 g per injectable ampoule.
- 6. A method of treating manic-depressive psychosis by administering an effective amount of a compound as recited in claim 1.
Priority Claims (1)
Number |
Date |
Country |
Kind |
77 08692 |
Mar 1977 |
FRX |
|
Parent Case Info
This application is a continuation-in-part of copending application Ser. No. 888,202, filed Mar. 20, 1978 now U.S. Pat. No. 4,199,601.
US Referenced Citations (4)
Foreign Referenced Citations (1)
Number |
Date |
Country |
1090779 |
Nov 1967 |
GBX |
Non-Patent Literature Citations (1)
Entry |
Teraoka, "Hoppe-Seyler Zeitscrift fur Physiologische Chemie," 145 242 (1925). |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
888202 |
Mar 1978 |
|